Hrt Financial LP Magenta Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $125,189 - $256,761	-49,094 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $130,724 - $245,809	29,509 Added 150.67%	49,094 $217,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $118,880 - $193,695	19,585 New	19,585 $142,000
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $74,536 - $188,381	-12,361 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.07 - $15.84 $112,114 - $195,798	12,361 New	12,361 $187,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.